AeroLeads people directory · profile
David Baker Email & Phone Number
Head of Corporate Development
at
Nospharma
1 work email found
@shire.com
5 phones found area 484
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Head of Corporate Development
Location
Philadelphia, Pennsylvania, United States
Company size
Who is David Baker? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
David Baker is listed as Head of Corporate Development at Nospharma, a company with 3 employees, based in Philadelphia, Pennsylvania, United States. AeroLeads shows a work email signal at shire.com, phone signal with area code 484, and a matched LinkedIn profile for David Baker.
David Baker previously worked as Board Director at Devonian Health Group Inc. and Board Director at Gri Bio, Inc.. David Baker holds Mba, Marketing from Duke University - The Fuqua School Of Business.
Company email context
Email format at Nospharma
This section adds company-level context without repeating David Baker's masked contact details.
{first_initial}{last}@shire.com
86% confidence
AeroLeads found 1 current-domain work email signal for David Baker. Compare company email patterns before reaching out.
Profile bio
About David Baker
Accomplished life sciences executive with experience in large, medium, and small/start up pharmaceutical companies. Brand management leadership experience on five different billion dollar brands in three therapeutic categories.Specialties: Executive leadership; Marketing; Product Launches; Commercial Assessment; Business Development & Licensing; Analysis; Fund Raising; Problem Solving; Mentoring and Developing Talent
Listed skills include Strategy, Pharmaceutical Industry, Product Launch, Leadership, and 46 others.
Current workplace
David Baker's current company
Company context helps verify the profile and gives searchers a useful next step.
Nospharma
16 roles · 41 years
David Baker work experience
A career timeline built from the work history available for this profile.
Board Director
CurrentDevonian (TSXV: GSD; OTCQB: DVHGF) is a late stage botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. This strategy is supported by FDA set.
May 2023 - Present
Board Director
CurrentGRI Bio (NASDAQ: GRI) is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune.
Apr 2023 - Present
Head Of Corporate Development
CurrentNospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University. We aim to deliver novel and effective therapeutics as quickly as.
Jul 2023 - Present
Member
CurrentRobin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential.
Jun 2023 - Present
Board Director
Benchworks is a company comprised of a steadily growing number of business units and wholly owned subsidiaries primarily dedicated to serving the life science industry. Benchworks operating units include Benchworks Health, a strategic communications firm with offices in Chestertown, Maryland and Philadelphia.
Aug 2018 - May 2024
President & Ceo
Took company public in 2021. Led company through M&A process resulting in successful merger with GRI Bio (NASDAQ: GRI).
Jan 2019 - May 2023
Chief Operating Officer & Acting Ceo
Vallon Pharmaceuticals Inc. (NASDAQ: VLON), founded in 2018 and headquartered in Philadelphia, is an emerging pharmaceutical company focused on the development of new medications to help patients with central nervous system (CNS) disorders including ADHD and Narcolepsy. ADAIR (Abuse Deterrent Amphetamine Immediate Release) is the company’s lead.
Jan 2018 - Dec 2018
Interim Ceo
Led company through M&A process resulting in successful merger with Arcturus Therapeutics (NASDAQ: ARCT).
Jun 2017 - Nov 2017
Chief Commercial Officer
Alcobra Ltd., was a Tel Aviv-based pharmaceutical company focused on the development of new medications to help patients with cognitive disorders including ADHD and Fragile X Syndrome. Led all pre-launch commercial analysis and preparation for all pipeline products, as well as leading business development efforts and supporting investor relations.
Jan 2014 - Jun 2017
Vice President, Innovation & Imagination - Behavioral Health Business Unit
Identified, evaluated, licensed, and developed novel products and services that meet unmet needs for patients with Behavioral Health disorders including ADHD, Autism, Binge Eating Disorder, Depression and PTSD. These products and services included and went beyond Rx therapies including diagnostics, complementary therapy, and mHealth tools and applications.
Jun 2012 - Dec 2013
Vice President, Commercial Lead - Adhd Business Unit
Oversaw portfolio decisions for multi-product business unit; Built pipeline of future ADHD and CNS products through acquisition and development; Led efforts to geographically expand ADHD/CNS product line beyond North America and Western Europe; Led newly formed Customer & Patient Excellence team
Feb 2009 - Jun 2012
Vice President, Product General Manager
General Manager with global responsibilities for Vyvanse and Adderall XR across Marketing, Sales, R&D, Regulatory, and Manufacturing functions with full P&L accountability
Aug 2006 - Feb 2009
Vice President, Marketing, Adhd Products
Head of US Marketing for multiple ADHD products both on the market and under development including Vyvanse, Adderall XR, Daytrana, Intuniv, and SPD 465
Apr 2004 - Aug 2006
Senior Director Of Marketing
Merck
Multiple positions in Marketing, Marketing Support, Market Development ( MSL Manager), Business Development, and Market Research with experience on multiple brands including Fosamax, Zocor, Mevacor, and Maxalt
1990 - 2004
~14 yrs
Account Executive
Property-casualty insurance underwriter for mid-large accounts ($100,000 - $2,000,000)
1985 - 1988
~3 yrs
2 education records
David Baker education
Mba, Marketing
Duke University - The Fuqua School Of Business
Ba, Economics
Duke University
FAQ
Frequently asked questions about David Baker
Quick answers generated from the profile data available on this page.
What company does David Baker work for?
David Baker works for Nospharma.
What is David Baker's role at Nospharma?
David Baker is listed as Head of Corporate Development at Nospharma.
What is David Baker's email address?
AeroLeads has found 1 work email signal at @shire.com for David Baker at Nospharma.
What is David Baker's phone number?
AeroLeads has found 5 phone signal(s) with area code 484 for David Baker at Nospharma.
Where is David Baker based?
David Baker is based in Philadelphia, Pennsylvania, United States while working with Nospharma.
What companies has David Baker worked for?
David Baker has worked for Nospharma, Devonian Health Group Inc., Gri Bio, Inc., Robin Hood Ventures, and Benchworks.
How can I contact David Baker?
You can use AeroLeads to view verified contact signals for David Baker at Nospharma, including work email, phone, and LinkedIn data when available.
What schools did David Baker attend?
David Baker holds Mba, Marketing from Duke University - The Fuqua School Of Business.
What skills is David Baker known for?
David Baker is listed with skills including Strategy, Pharmaceutical Industry, Product Launch, Leadership, Cross Functional Team Leadership, Market Research, Strategic Planning, and Pharmaceutical Sales.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial